RDY
What one share of Dr. Reddy’s Laboratories Limited holds
Pharmaceutical Preparations
Established in 1984, we are an integrated global pharmaceutical company committed to accelerating access to affordable and innovative medicines. Our reportable operating segments are as follows:
Dr. Reddy’s Laboratories Limited’s numbers from its SEC filings, divided by its shares. Results cover the latest fiscal year to 2026-03-31; the balance sheet is as of 2026-03-31.
| Sales | $4.57 |
|---|---|
| Profit | $0.58 |
| Capex (buildings and equipment) | $0.32 |
| Free cash flow | $0.45 |
| Dividends | $0.09 |
| Cash and investments | $0.20 |
| Debt | $0.23 |
| Book value | $4.83 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | $2.77 | $0.36 | $0.21 | $0.52 | — | $2.27 |
| 2017 | $2.52 | $0.22 | $0.22 | $0.17 | — | $2.24 |
| 2018 | $2.65 | $0.18 | $0.17 | $0.16 | $0.06 | $2.34 |
| 2019 | $2.65 | $0.32 | $0.12 | $0.38 | $0.06 | $2.44 |
| 2020 | $2.97 | $0.33 | $0.08 | $0.42 | $0.06 | $2.48 |
| 2021 | $3.07 | $0.28 | $0.16 | $0.42 | $0.07 | $2.85 |
| 2022 | $3.46 | $0.38 | $0.24 | $0.22 | $0.07 | $3.03 |
| 2023 | $3.68 | $0.68 | $0.17 | $0.71 | $0.37 | $3.39 |
| 2024 | $4.05 | $0.81 | $0.24 | $0.42 | $0.10 | $4.05 |
| 2025 | $4.62 | $0.80 | $0.39 | $0.27 | $0.09 | $4.69 |
| 2026 | $4.57 | $0.58 | $0.32 | $0.45 | $0.09 | $4.83 |